Zhen Bo Su

Polyrey Medical Tech (Suzhou) Co., Ltd. engages in the development, manufacture, and sale of medical instruments in treating vascular diseases. It focuses on coronary catheterization and outer periphery balloon dilatation catheters. The company was founded by Lie Tang on August 3, 2011 and is headquartered in Suzhou, China.

Genetron Holdings, Ltd. engages in precision oncology. It provides cancer molecular profiling by using technologies in molecular biology and data science to transform cancer treatment. It products and services include diagnosis and monitoring through both LDT and IVD products. Its LDT portfolio consists of both specifically designed focused and comprehensive gene panel testing services. It also develops liver cancer early screening products. The company was founded by Si Zhen Wang, Hai Yan, and Wei Wu He in 2015 and is headquartered in Beijing, China.

Chongqing TCR CURE Biopharma Technology Co., Ltd is a company that develops immunotherapy for T cell cancer. The company is based in Chongqing, China. and has subsidiaries in China. The Chinese company was founded in 2016 by Wei-Wu He, Zhen Bo Su, Qi-Jing Li, Pin Wang. Qi-Jing Li has been the CEO since 2016.

Shenzhen Share Investment LP is an independent venture capital firm founded in 2007 by Bai Wen Tao, Cui Xin Xin, and Huang Fan Zhi. The firm is headquartered in Shenzhen, China.